Barton J R, O'brien J M, Bergauer N K, Jacques D L, Sibai B M
Maternal-Fetal Medicine, Central Baptist Hospital, Lexington, Kentucky 40503, USA.
Am J Obstet Gynecol. 2001 Apr;184(5):979-83. doi: 10.1067/mob.2001.112905.
Limited information is available regarding the progression of disease in women with mild gestational hypertension. Our purpose was to describe the prognostic signs in the natural course of mild gestational hypertension and pregnancy outcomes in women who were remote from term with mild gestational hypertension that was expectantly managed.
Women with mild gestational hypertension participating in an outpatient hypertension monitoring program were studied. Inclusion criteria were patients with a singleton pregnancy between 24 and 35 weeks' gestation who had no proteinuria by dipstick (0 or trace) on the first 2 days of program participation. Progression to preeclampsia was the primary outcome. The rate of progression to severe preeclampsia, obstetric complications, and neonatal outcomes were secondary measures. Data were compared by independent Student t and Fisher exact tests where applicable.
A total of 748 patients were studied during the observation period; preeclampsia (persistent proteinuria > or = 1+) developed in 343 (46%), and 72 (9.6%) had antepartum progression to severe preeclampsia. No significant differences in maternal age, race, marital status, or tobacco use were observed between those women in whom persistent proteinuria developed and those in whom it did not develop. Gestational age of the infants at delivery (36.5 +/- 2.4 vs 37.4 +/- 2.0 weeks), birth weight (2752 +/- 767 vs 3038 +/- 715 g), incidence of small-for-gestational-age newborns (24.8% vs 13.8%), and duration of neonatal hospital stay (7.1 +/- 10 vs 5.0 +/- 9.3 days) differed significantly in the patients with versus those without proteinuria (P <.001 for all).
In patients with mild gestational hypertension remote from term, 46% ultimately had preeclampsia, with progression to severe disease in 9.6%. The development of proteinuria is associated with an earlier gestational age at delivery, lower birth weight, and an increased incidence of small-for-gestational age newborns.
关于轻度妊娠高血压女性疾病进展的信息有限。我们的目的是描述轻度妊娠高血压自然病程中的预后征象以及对轻度妊娠高血压进行期待治疗且孕周尚早的女性的妊娠结局。
对参与门诊高血压监测项目的轻度妊娠高血压女性进行研究。纳入标准为妊娠24至35周的单胎妊娠患者,在参与项目的头2天尿试纸检测无蛋白尿(0或微量)。进展为子痫前期是主要结局。进展为重度子痫前期的发生率、产科并发症及新生儿结局为次要指标。适用时,数据通过独立样本t检验和Fisher精确检验进行比较。
在观察期内共研究了748例患者;343例(46%)发生子痫前期(持续性蛋白尿≥1 +),72例(9.6%)产前进展为重度子痫前期。发生持续性蛋白尿的女性与未发生持续性蛋白尿的女性在产妇年龄、种族、婚姻状况或吸烟情况方面未观察到显著差异。有蛋白尿与无蛋白尿的患者相比,分娩时婴儿的孕周(36.5±2.4 vs 37.4±2.0周)、出生体重(2752±767 vs 3038±715 g)、小于胎龄新生儿的发生率(24.8% vs 13.8%)以及新生儿住院时间(7.1±10 vs 5.0±9.3天)存在显著差异(所有P <.001)。
孕周尚早的轻度妊娠高血压患者中,46%最终发生子痫前期,9.6%进展为重度疾病阶段。蛋白尿的出现与分娩时更早的孕周、更低的出生体重以及小于胎龄新生儿发生率增加有关。